RedHill Biopharma reported $900K in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Cara Therapeutics USD 0 0 Mar/2025
Clal Biotechnology ILS 25.96M 18.48M Dec/2023
Compugen USD 0 0 Dec/2024
RedHill Biopharma USD 900K 710K Dec/2025